Prevalence of Extensively Drug Resistant Salmonella typhi and its Susceptibility against Meropenem, Tigecycline, Fosfomycin and Azithromycin among Clinical Isolates from a Tertiary Care Hospital Laboratory : Susceptibility in Extensively Drug Resistant Salmonella typhi

Zona Irfan; Faisal Iqbal Afridi; Ambreen Fatima; Hira Zafar; Yousra Muhammad Pervaiz; Lubna Farooq

doi:10.54393/pjhs.v5i08.1787

Authors

Zona Irfan Department of Pathology, Fazaia Ruth Pfau Medical College, Karachi, Pakistan
Faisal Iqbal Afridi Department of Microbiology, Ziauddin University, Karachi, Pakistan
Ambreen Fatima Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan
Hira Zafar Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan
Yousra Muhammad Pervaiz Department of Microbiology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan
Lubna Farooq Department of Pharmacology, Baqai Medical University, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i08.1787

Keywords:

Drug-Resistant, Salmonella typhi, Antimicrobial Susceptibility, Meropenem

Abstract

The emergence of Extensively Drug-Resistant (XDR) Salmonella typhi in Pakistan has posed a significant public health challenge. Traditional antibiotics, including ampicillin, chloramphenicol, and fluoroquinolones, have become ineffective due to widespread resistance, necessitating the exploration of alternative treatment options. Objective: To assess the in vitro efficacy of four antibiotics fosfomycin, tigecycline, meropenem and azithromycin against XDR Salmonella typhi strains isolated from patients in Karachi, Pakistan. Methods: A cross-sectional study was conducted at the Department of Microbiology, Ziauddin University Hospital, Karachi, over six months. Blood samples from both inpatients and outpatients aged 1 to 60 years were collected for culture and sensitivity testing. Antibiotic susceptibility was determined using the standard disc diffusion method. Data were analyzed to evaluate the effectiveness of the selected antibiotics against XDR Salmonella typhi. Results: The susceptibility patterns of Salmonella typhi and XDR Salmonella typhi revealed that meropenem, azithromycin, tigecycline, and fosfomycin were effective in all tested samples. Conversely, antibiotics such as ampicillin, aztreonam, cefixime, ceftriaxone, chloramphenicol, co-trimoxazole, and ciprofloxacin demonstrated resistance, with varying patterns observed between Salmonella typhi and XDR Salmonella typhi. The distribution of XDR and Non-XDR Salmonella typhi cases by gender and age, with no significant association found between these variables and XDR status. Conclusions: Meropenem and azithromycin remain effective against XDR Salmonella typhi; however, fosfomycin and tigecycline present promising alternatives. These findings underscore the need for continuous surveillance and the development of new treatment strategies to combat the rising threat of XDR Salmonella typhi in Pakistan.

References

Dróżdż M, Małaszczuk M, Paluch E, Pawlak A. Zoonotic potential and prevalence of Salmonella serovars isolated from pets. Infection Ecology & Epidemiology. 2021 Jan; 11(1): 1975530. doi: 10.1080/20008686.2021.1975530. DOI: https://doi.org/10.1080/20008686.2021.1975530

Li T, Qiang N, Bao Y, Li Y, Zhao S, Chong KC et al. Global burden of enteric infections related foodborne diseases, 1990–2021: findings from the Global Burden of Disease study 2021. Science in One Health. 2024 Aug: 100075. doi: 10.1016/j.soh.2024.100075. DOI: https://doi.org/10.1016/j.soh.2024.100075

Goh RS, Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Kueh MT et al. The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions. The Lancet Regional Health Western Pacific. 2024 Aug; 49. doi: 10.1016/j.lanwpc.2024.101138. DOI: https://doi.org/10.1016/j.lanwpc.2024.101138

Ahmad M, Saeed M, Rasheed F, Rasool MH, Jamil I, Saba N et al. Typhoid Fever: Pakistan's Unique Challenges and Pragmatic Solutions. Journal of Islamabad Medical & Dental College. 2024 Apr; 13(1): 151-61. doi: 10.35787/jimdc.v13i1.1179. DOI: https://doi.org/10.35787/jimdc.v13i1.1179

Kuehn R, Stoesser N, Eyre D, Darton TC, Basnyat B, Parry CM. Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. Cochrane Database of Systematic Reviews. 2022 Nov; (11). doi: 10.1002/14651858.CD010452.pub2. DOI: https://doi.org/10.1002/14651858.CD010452.pub2

Masuet-Aumatell C and Atouguia J. Typhoid fever infection–Antibiotic resistance and vaccination strategies: A narrative review. Travel Medicine and Infectious Disease. 2021 Mar; 40: 101946. doi: 10.1002/14651858.CD010452.pub2. DOI: https://doi.org/10.1016/j.tmaid.2020.101946

Saeed N, Usman M, Khan EA. An overview of extensively drug-resistant Salmonella typhi from a tertiary care hospital in Pakistan. Cureus. 2019 Sep; 11(9): e5663. doi: 10.7759/cureus.5663. DOI: https://doi.org/10.7759/cureus.5663

Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ et al. Extensively drug‐resistant (XDR) typhoid: evolution, prevention, and its management. BioMed Research International. 2020 May; 2020(1): 6432580. doi: 10.1155/2020/6432580. DOI: https://doi.org/10.1155/2020/6432580

Jabeen K, Saleem S, Jahan S, Nizamudin S, Arshad F, Huma ZE et al. Molecular characterization of extensively drug resistant Salmonella enterica Serovar Typhi clinical isolates from Lahore, Pakistan. Infection and Drug Resistance. 2023 Dec: 2987-3001. doi: 10.2147/IDR.S406253. DOI: https://doi.org/10.2147/IDR.S406253

Ahdi SG, Batool A, Siddique AW, Waqas A, Gul R, Saleem F. The menace of drug resistant Salmonella typhi in children: Experience from a tertiary care hospital in Pakistan. Pakistan Pediatric Journal. 2022 Oct; 46(3): 260-7.

Li X, Cao H, Chen JH, Ng YZ, Fung KK, Cheng VC et al. Genomic investigation of Salmonella typhi in Hong Kong revealing the predominance of genotype 3.2. 2 and the first case of an extensively drug-resistant H58 genotype. Microorganisms. 2023 Mar; 11(3): 667. doi: 10.3390/microorganisms11030667. DOI: https://doi.org/10.3390/microorganisms11030667

Manesh A, Balaji V, Kumar DR, Rupali P. A case of clinical and microbiological failure of azithromycin therapy in Salmonella enterica serotype Typhi despite low azithromycin MIC. International Journal of Infectious Diseases. 2017 Jan; 54: 62-3. doi: 10.1016/j.ijid.2016.11.409. DOI: https://doi.org/10.1016/j.ijid.2016.11.409

Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Diagnostic microbiology. The nonfermentative gram-negative bacilli. In: Koneman EW, editor. Color atlas and textbook of diagnostic microbiology. 5th Edition. Philadelphia: Lippincott-Raven Publishers; 1997. 253-320.

Chowdhury SR, Ahamed Z, Roy K, Al Noman A, Haroon RM, Mondol KC. Emerging threats of antibiotic resistance in Salmonella typhi and Salmonella paratyphi A among enteric fever cases of Dhaka, Bangladesh. African Journal of Bacteriology Research. 2022 Jan; 14(1): 8-15. doi:10.5897/JBR2021.0340.

Delgado-Valverde M, Valiente-Mendez A, Torres E, Almirante B, Gómez-Zorrilla S, Borrell N et al. MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 2017 May; 72(5): 1478-87. doi.org/10.1093/jac/dkw562. DOI: https://doi.org/10.1093/jac/dkw562

Polsfuss S, Bloemberg GV, Giger J, Meyer V, Hombach M. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates. Journal of Antimicrobial Chemotherapy. 2012 Jan; 67(1): 159-66. doi: 10.1093/jac/dkr400. DOI: https://doi.org/10.1093/jac/dkr400

Ali AM, Hussain AB, Kıyanı AM. First Case of Azithromycin Resistance in Salmonella typhi, Isolated in a Patient with Prosthetic Valve Replacement. Journal of Microbiology and Infectious Diseases. 2021 Mar; 11(01): 32-5. doi: 10.5799/jmid.897210. DOI: https://doi.org/10.5799/jmid.897210

Octavia S, Chew KL, Lin RT, Teo JW. Azithromycin-Resistant Salmonella enterica Serovar Typhi AcrB-R717Q/L, Singapore. Emerging Infectious Diseases. 2021 Feb; 27(2): 624. doi: 10.3201/eid2702.203874. DOI: https://doi.org/10.3201/eid2702.203874

Yasin N, Rahman H, Sarwar Y, Qasim M, Nisa I, Ikram A et al. Salmonella typhi from Northwest Pakistan: Molecular strain typing and drug resistance signature. Microbial Drug Resistance. 2022 Jan; 28(1): 120-6. doi: 10.1089/mdr.2020.0304. DOI: https://doi.org/10.1089/mdr.2020.0304

Elnasser Z, Elsamarneh R, Obeidat H, Amarin Z, Jaradat S, Kaplan N. In-vitro activity of tigecycline against multidrug-resistant gram negative bacteria: the experience of a university hospital. Journal of Infection and Public Health. 2021 Apr; 14(4): 478-83. doi: 10.1016/j.jiph.2020.12.013. DOI: https://doi.org/10.1016/j.jiph.2020.12.013